Trials / Completed
CompletedNCT00160277
Efficacy and Safety of Moxonidine in Indian Patients
Open Label, Multi-Center, Force-Titration Study to Evaluate the Efficacy and Safety of Moxonidine in Ambulatory Subjects With Essential Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (planned)
- Sponsor
- Solvay Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate efficacy and safety of Moxonidine in Indian subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Moxonidine |
Timeline
- Start date
- 2005-07-01
- First posted
- 2005-09-12
- Last updated
- 2009-01-30
Locations
3 sites across 1 country: India
Source: ClinicalTrials.gov record NCT00160277. Inclusion in this directory is not an endorsement.